SINTX Technologies, manufacturer of silicon nitride ceramic for medical and non-medical applications, was issued U.S. Patent No. 10,806,831 covering antibacterial biomedical implants and associated materials. This patent broadly covers a variety of biomedical implants wherein the company’s silicon nitride is applied to improve the antibacterial characteristics of the implant.
In the biomedical space, SINTX can now add its material to biomaterials such as PEEK and titanium. The company has developed a composite of silicon nitride and PEEK, and expects to launch the product in early 2021.
SINTX provides silicon nitride in other forms such as sintered powders and soluble fractions. The newly-issued patent is a milestone in SINTX’s strategy to leverage the antipathogenic properties of silicon nitride, and adds to a growing IP portfolio in that space.
“The antibacterial characteristics of SINTX’s silicon nitride were identified in 2012, and have been confirmed by multiple independent studies. We have developed and tested powders, coatings, and composites of silicon nitride that extend the technology to other material platforms,” said Dr. Sonny Bal President, and CEO of SINTX Technologies.